Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET).
作者信息
Harrington K, Hall E, Hawkins M, Henry A, MacKay R, Maughan T, McDonald A, Nutting C, Oelfke U, Sebag-Montefiore D, Sharma R A, van Herk M, Faivre-Finn C
机构信息
Institute of Cancer Research, London, UK.
Cancer Research UK/MRC Oxford Institute for Radiation Oncology, Oxford, UK.
出版信息
Clin Oncol (R Coll Radiol). 2017 Nov;29(11):707-710. doi: 10.1016/j.clon.2017.07.016. Epub 2017 Aug 12.
Abstract
摘要
相似文献
1
Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET).介绍英国癌症研究先进放射治疗技术网络（ART-NET）。
Clin Oncol (R Coll Radiol). 2017 Nov;29(11):707-710. doi: 10.1016/j.clon.2017.07.016. Epub 2017 Aug 12.
2
Response to a Request for Clarification Regarding the Advanced Radiotherapy Technologies Network (ART-NET).对关于先进放射治疗技术网络（ART-NET）的澄清请求的回复。
Clin Oncol (R Coll Radiol). 2018 Jun;30(6):391-393. doi: 10.1016/j.clon.2018.01.021. Epub 2018 Mar 2.
3
A Request for Clarification Regarding the Advanced Radiotherapy Technologies Network (ART-NET).关于先进放射治疗技术网络（ART-NET）的澄清请求。
Clin Oncol (R Coll Radiol). 2018 Jun;30(6):391. doi: 10.1016/j.clon.2018.01.020. Epub 2018 Feb 16.
4
The advanced radiotherapy network (ART-NET) UK lung stereotactic ablative radiotherapy survey: national provision and a focus on image guidance.英国先进放射治疗网络（ART-NET）肺部立体定向消融放疗调查：全国供应情况及对图像引导的关注
Br J Radiol. 2019 Jun;92(1098):20180988. doi: 10.1259/bjr.20180988. Epub 2019 Apr 24.
5
UK adaptive radiotherapy practices for head and neck cancer patients.英国对头颈部癌患者的适应性放射治疗实践。
BJR Open. 2020 Dec 11;2(1):20200051. doi: 10.1259/bjro.20200051. eCollection 2020.
6
Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.将先进的放疗技术相结合，以最大限度地提高 III 期非小细胞肺癌的安全性和肿瘤控制概率。
Strahlenther Onkol. 2012 Oct;188(10):894-900. doi: 10.1007/s00066-012-0161-9. Epub 2012 Aug 31.
7
The management of lung cancer: a UK survey of oncologists.肺癌管理：英国肿瘤学家调查。
Clin Oncol (R Coll Radiol). 2012 Aug;24(6):402-9. doi: 10.1016/j.clon.2012.03.005. Epub 2012 Apr 17.
8
Survey of advanced radiation technologies used at designated cancer care hospitals in Japan.日本指定癌症治疗医院使用的先进放射技术调查。
Jpn J Clin Oncol. 2014 Jan;44(1):72-7. doi: 10.1093/jjco/hyt161. Epub 2013 Oct 30.
9
The Development of Therapeutic Radiographers in Imaging and Adaptive Radiotherapy Through Clinical Trial Quality Assurance.通过临床试验质量保证，发展影像学和适应性放疗中的治疗放射技师。
Clin Oncol (R Coll Radiol). 2021 Jul;33(7):461-467. doi: 10.1016/j.clon.2021.02.009. Epub 2021 Mar 23.
10
Accelerated Radiotherapy Alone Versus Chemoradiation in Locally Advanced Carcinoma Cervix: Long-Term Outcomes.局部晚期宫颈癌单纯加速放疗与放化疗的长期疗效比较
Cureus. 2024 Jul 22;16(7):e65154. doi: 10.7759/cureus.65154. eCollection 2024 Jul.
引用本文的文献
1
The advanced radiotherapy network (ART-NET) UK lung stereotactic ablative radiotherapy survey: national provision and a focus on image guidance.英国先进放射治疗网络（ART-NET）肺部立体定向消融放疗调查：全国供应情况及对图像引导的关注
Br J Radiol. 2019 Jun;92(1098):20180988. doi: 10.1259/bjr.20180988. Epub 2019 Apr 24.
2
Added value of diffusion-weighted MRI for nodal radiotherapy planning in pelvic malignancies.扩散加权 MRI 在盆腔恶性肿瘤淋巴结放疗计划中的增值作用。
Clin Transl Oncol. 2019 Oct;21(10):1383-1389. doi: 10.1007/s12094-019-02068-0. Epub 2019 Mar 13.
3
Assessing the Role of Artificial Intelligence (AI) in Clinical Oncology: Utility of Machine Learning in Radiotherapy Target Volume Delineation.评估人工智能（AI）在临床肿瘤学中的作用：机器学习在放射治疗靶区勾画中的应用
Medicines (Basel). 2018 Dec 11;5(4):131. doi: 10.3390/medicines5040131.
本文引用的文献
1
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.大分割放疗与常规分割放疗用于中危局限性前列腺癌患者的比较：随机、非劣效性3期CHHiP试验的2年患者报告结局
Lancet Oncol. 2015 Dec;16(16):1605-16. doi: 10.1016/S1470-2045(15)00280-6. Epub 2015 Oct 28.
2
Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom.IMPORT HIGH试验（CRUK/06/003）对英国乳腺癌放疗实践的临床影响。
Br J Radiol. 2015;88(1056):20150453. doi: 10.1259/bjr.20150453. Epub 2015 Oct 22.
3
Dose escalation in lung cancer: have we gone full circle?肺癌中的剂量递增：我们是否已回到原点？
Lancet Oncol. 2015 Feb;16(2):125-7. doi: 10.1016/S1470-2045(15)70001-X. Epub 2015 Jan 16.
4
MR guidance in radiotherapy.放射治疗中的磁共振引导。
Phys Med Biol. 2014 Nov 7;59(21):R349-69. doi: 10.1088/0031-9155/59/21/R349. Epub 2014 Oct 16.
5
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.英国乳腺癌放射治疗标准化（START）试验——早期乳腺癌放射治疗的分割方案优化：两项随机对照临床试验的 10 年随访结果。
Lancet Oncol. 2013 Oct;14(11):1086-1094. doi: 10.1016/S1470-2045(13)70386-3. Epub 2013 Sep 19.
6
Stereotactic body radiotherapy for oligometastases.寡转移瘤的立体定向体部放疗。
Lancet Oncol. 2013 Jan;14(1):e28-37. doi: 10.1016/S1470-2045(12)70510-7.
7
Advances in radiotherapy.放射治疗的进展
BMJ. 2012 Dec 4;345:e7765. doi: 10.1136/bmj.e7765.
8
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.腮腺保留调强放疗与常规放疗治疗头颈部肿瘤（PARSPORT）：一项 3 期多中心随机对照试验。
Lancet Oncol. 2011 Feb;12(2):127-36. doi: 10.1016/S1470-2045(10)70290-4. Epub 2011 Jan 12.
9
Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.立体定向体部放射治疗早期非小细胞肺癌：一项前瞻性II期研究的四年结果
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):677-82. doi: 10.1016/j.ijrobp.2008.11.042. Epub 2009 Feb 27.
10
Hypofractionation in clinical trials for prostate cancer.前列腺癌临床试验中的大分割放疗
Clin Oncol (R Coll Radiol). 2007 Jun;19(5):287-8. doi: 10.1016/j.clon.2007.03.007. Epub 2007 Apr 24.
Zotero 插件